Search - tctmd.com

Displaying 841 - 860 of 15660

Sort: Relevancy | Date

Presentation TCT 2016

MATRIX Critique: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, Frederick Feit

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty IV: Millipede

Presenter: Ted Feldman, Scott Lim, Jason H. Rogers

October 31, 2016

Presentation TCT 2016

Post-PCI FFR Measurements: Lessons From FAME I and II

Presenter: Allen Jeremias, Nico H.J. Pijls, Zsolt Piroth

October 31, 2016

Presentation TCT 2016

Flash Debate: Point 4D-CT Leaflet Thickening Is an Imaging Curiosity With No Clinical Relevance!

Presenter: Raj Makkar, Lars Sondergaard, Ganesh Manoharan

October 31, 2016

Presentation TCT 2016

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: Vulnerable Plaque Is the Single Most Important Factor!

Presenter: Ran Kornowski, Michel R. Le May, Tej Sheth

October 31, 2016

Presentation TCT 2016

Early Insights From the DELTA-2 Registry

Presenter: Seung-Jung Park, Leif Thuesen, Alaide Chieffo

October 31, 2016

Presentation TCT 2016

Clinical Risk Assessment and Health Status Goals in the CHIP Population

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Adam C. Salisbury

October 31, 2016

Presentation TCT 2016

Acute Cardiogenic Shock Treatment Algorithm 3: The Case for First-line Use of ECMO

Presenter: Simon R. Dixon, Holger Thiele, A. Reshad Garan

October 31, 2016

Presentation TCT 2016

The Alphabet Soup of SFA Scaffolds and Their Outcomes: BMS, VMI, DES, PTFE

Presenter: Tony Das, Koen Deloose, Ehrin J. Armstrong

October 31, 2016

Presentation TCT 2016

Intervention for Venous Disease

Presenter: Raghu Kolluri, Vishal Kapur

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty III: Guided Delivery Systems Results, Device Iterations, and Future Directions

Presenter: Ted Feldman, Scott Lim, Horst Sievert

October 31, 2016

Presentation TCT 2016

Failure Modes of Bioresorbable Scaffolds: From the Obvious (Strut Thickness Considerations) to the Novel (Intraluminal Scaffold Dismantling)

Presenter: Elazer R. Edelman, Juan F. Granada

October 31, 2016

Presentation TCT 2016

What Have We Learned From Contemporary Left Main Observational Studies IV? FLORENCE-LM Registry

Presenter: Seung-Jung Park, Leif Thuesen, David Antoniucci (RETIRED)

October 31, 2016

Presentation TCT 2016

Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS

Presenter: Sunil V. Rao, Harvey D. White, Salvatore Brugaletta

October 31, 2016

Presentation TCT 2016

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: The Degree of Stenosis/Ischemia Is Most Important!

Presenter: Ran Kornowski, Michel R. Le May, Anthony H. Gershlick

October 31, 2016

Presentation TCT 2016

Controversy 2. Global Clinical Trial Experiences on Bioprosthetic Leaflet Thickening/Thrombosis: Updates and Insights

Presenter: Raj Makkar, Lars Sondergaard

October 31, 2016

Presentation TCT 2016

Contrast as a Hyperemic Agent: Easier, but Sufficient?

Presenter: Allen Jeremias, Nico H.J. Pijls, Nils Johnson

October 31, 2016

Presentation TCT 2016

Acute Cardiogenic Shock Treatment Algorithm 2: The Case for First-line Use of Impella

Presenter: Simon R. Dixon, Holger Thiele, Jerry D Estep

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty II: Mitralign Trial Results and Future Directions

Presenter: Ted Feldman, Scott Lim, Azeem Latib

October 31, 2016

Presentation TCT 2016

Flash Perspective: The Best Way to Become a (New) CHIP Operator: When, Where, How, and Why to Train: An Early Career Perspective - A Dedicated Fellowship Is Necessary for New Trainees to Get Into the CHIP Space!

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Robert F. Riley

October 31, 2016

Advertisement

MATRIX Critique: Pros and Cons

Direct Annuloplasty IV: Millipede

Post-PCI FFR Measurements: Lessons From FAME I and II

Flash Debate: Point 4D-CT Leaflet Thickening Is an Imaging Curiosity With No Clinical Relevance!

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: Vulnerable Plaque Is the Single Most Important Factor!

Early Insights From the DELTA-2 Registry

Clinical Risk Assessment and Health Status Goals in the CHIP Population

Acute Cardiogenic Shock Treatment Algorithm 3: The Case for First-line Use of ECMO

The Alphabet Soup of SFA Scaffolds and Their Outcomes: BMS, VMI, DES, PTFE

Intervention for Venous Disease

Direct Annuloplasty III: Guided Delivery Systems Results, Device Iterations, and Future Directions

Failure Modes of Bioresorbable Scaffolds: From the Obvious (Strut Thickness Considerations) to the Novel (Intraluminal Scaffold Dismantling)

What Have We Learned From Contemporary Left Main Observational Studies IV? FLORENCE-LM Registry

Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: The Degree of Stenosis/Ischemia Is Most Important!

Controversy 2. Global Clinical Trial Experiences on Bioprosthetic Leaflet Thickening/Thrombosis: Updates and Insights

Contrast as a Hyperemic Agent: Easier, but Sufficient?

Acute Cardiogenic Shock Treatment Algorithm 2: The Case for First-line Use of Impella

Direct Annuloplasty II: Mitralign Trial Results and Future Directions

Flash Perspective: The Best Way to Become a (New) CHIP Operator: When, Where, How, and Why to Train: An Early Career Perspective - A Dedicated Fellowship Is Necessary for New Trainees to Get Into the CHIP Space!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content